Long term history of a congenital core-rod myopathy with compound heterozygous mutations in the Nebulin gene

Gilbert Wunderlich 1, Anna Brunn 2, Hülya-Sevcan Daimagüler 3,4, Tarik Bozoglu 3,4, Gereon R. Fink 1,5, Helmar C. Lehmann 1, Joachim Weis 6 and Sebahattin Cirak 3,4

1Department of Neurology, University Hospital Cologne, 50937 Cologne, Germany; 2 Institute for Neuropathology, University of Cologne, 50937 Cologne, Germany; 3 Department of Pediatrics, University Hospital Cologne, 50937 Cologne, Germany; 4 Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany; 5 Cognitive Neuroscience, Institute of Neuroscience and Medicine, Research Centre Jülich, 52428 Jülich, Germany; 6 Institute for Neuropathology, RWTH University Hospital Aachen, 52074 Aachen, Germany

Mutations in the Nebulin gene (NEB) may cause core-rod myopathy. The large size of the gene so far prevented inclusion of its routine analysis by didesoxy resequencing methodology in the diagnostic regime for muscular dystrophy cases. Here we report a 54-year-old female with a rare histological myopathy presentation of co-occurring cores and rods. The patient reported early childhood onset weakness. Muscle-MRI showed mainly proximal muscle involvement. We identified two compound heterozygous non-sense mutations in NEB (c.19653G > A, p.W6551* exon 127 and c.25441C > T, p.R8481* exon 182) using a comprehensive next generation sequencing (NGS)-based approach named Mendeliome Sequencing. The p.W6551* mutation has not been reported elsewhere. Early diagnosis by NGS shall be chased since even a scoliosis surgery at the age of 18 years had failed to initiate a neurological workup. Rather, cosmetic surgery for facial weakness had been performed recently, albeit with an unsatisfactory outcome.

Scarica il PDF